These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5952775)

  • 41. Pharmacotherapy for the opioid addict: agonists or antagonists?
    Ketchum JS; Jarvik ME
    Ration Drug Ther; 1979 Jan; 13(1):1-5. PubMed ID: 451229
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug use and abuse.
    McGlothlin WH
    Annu Rev Psychol; 1975; 26():45-64. PubMed ID: 1094931
    [No Abstract]   [Full Text] [Related]  

  • 43. Mazindol for relapse prevention to cocaine abuse in methadone-maintained patients.
    Margolin A; Avants SK; Kosten TR
    Am J Drug Alcohol Abuse; 1995 Nov; 21(4):469-81. PubMed ID: 8561098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insufficient information in drug-related hospital morbidity study.
    Newman RG
    Arch Gen Psychiatry; 2009 Mar; 66(3):331; author reply 331-2. PubMed ID: 19255384
    [No Abstract]   [Full Text] [Related]  

  • 45. [Iatrogenic addiction of pethidine: clinical feature and experience of detoxification].
    Jiang Z
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):85-7, 126. PubMed ID: 1499413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Objections to methadone regulations.
    Lowinger P
    N Engl J Med; 1972 Nov; 287(22):1154. PubMed ID: 5082210
    [No Abstract]   [Full Text] [Related]  

  • 47. Narcotic antagonists: the search accelerates.
    Maugh TH
    Science; 1972 Jul; 177(4045):249-50. PubMed ID: 5041023
    [No Abstract]   [Full Text] [Related]  

  • 48. Buprenorphine and naloxone interactions in methadone maintenance patients.
    Mendelson J; Jones RT; Welm S; Brown J; Batki SL
    Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The fate of drug addicts, taken care of by methadone therapy in the Canton of Vaud (1976-1986)].
    Meystre-Agustoni G; Martin J; Haller-Maslov E; Calanca A; Cereghetti A
    Rev Med Suisse Romande; 1988 Mar; 108(3):231-56. PubMed ID: 3375692
    [No Abstract]   [Full Text] [Related]  

  • 50. Health for life. Addiction: how to break the chain.
    Miller MC
    Newsweek; 2005 Dec; 146(24):58. PubMed ID: 16375164
    [No Abstract]   [Full Text] [Related]  

  • 51. [The dilemma of methadone and its implications].
    Harefuah; 1972 Aug; 83(4):168-9. PubMed ID: 5083983
    [No Abstract]   [Full Text] [Related]  

  • 52. Methadone treatment and rehabilitation service.
    Shanholtz MI
    Va Med Mon (1918); 1973 Oct; 100(10):956-8. PubMed ID: 4747466
    [No Abstract]   [Full Text] [Related]  

  • 53. Heroin addiction: a treatable disease.
    Krepick DS; Long BL
    Nurs Clin North Am; 1973 Mar; 8(1):41-52. PubMed ID: 4487808
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of narcotic-drug dependence by high-dosage methadone HCl technique; Dole-Nyswander program.
    JAMA; 1967 Sep; 201(12):956-7. PubMed ID: 6072635
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacotherapy II: narcotic and narcotic-antagonists analgesics.
    Gardier RW
    Dent Clin North Am; 1978 Jan; 22(1):125-41. PubMed ID: 23324
    [No Abstract]   [Full Text] [Related]  

  • 56. Policy progress for physician treatment of opiate addiction.
    Merrill JO
    J Gen Intern Med; 2002 May; 17(5):361-8. PubMed ID: 12047733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The outcome of the patient treated with methadone].
    Remy C
    Rev Med Brux; 1997 Sep; 18(4):312-6. PubMed ID: 9411666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacotherapy treatment in substance-dependent correctional populations: a review.
    Cropsey KL; Villalobos GC; St Clair CL
    Subst Use Misuse; 2005; 40(13-14):1983-99, 2043-8. PubMed ID: 16282089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How best to manage drug addicts?
    Br Med J (Clin Res Ed); 1982 May; 284(6325):1335-6. PubMed ID: 6803968
    [No Abstract]   [Full Text] [Related]  

  • 60. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
    Simon DL
    Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.